Sphingolipids in pulmonary fibrosis
- PMID: 25446881
- PMCID: PMC4291314
- DOI: 10.1016/j.jbior.2014.09.008
Sphingolipids in pulmonary fibrosis
Abstract
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by alveolar epithelial cell injury, accumulation of fibroblasts/myofibroblasts and deposition of extracellular matrix proteins. Levels of sphingosine-1-phosphate (S1P), a naturally occurring bioactive lipid, are elevated in bronchoalveolar fluids and lung tissues from IPF patients and animal models of pulmonary fibrosis. However, the in vivo contribution of S1P, regulated by its synthesis catalyzed by Sphingosine kinases (SphKs) 1 & 2 and catabolism by S1P phosphatases and S1P lyase (S1PL), in the pathogenesis of pulmonary fibrosis is not well defined. Microarray analysis of blood mononuclear cells from patients with IPF and SphK1-, SphK2- or S1PL-knockout mice and SphK inhibitor were used to assess the role of S1P in fibrogenesis. The expression of SphK1 negatively correlated with lung function and survival of patients with IPF. Further, the expressions of SphK1 and S1PL were increased in lung tissues from patients with IPF and bleomycin-challenged mice. Genetic knockdown of SphK1, but not SphK2, ameliorated bleomycin-induced pulmonary fibrosis in mice while deletion of S1PL (SGPL1(+/-)) in mice potentiated fibrosis post-bleomycin challenge. TGF-β increased the expression of SphK1 and S1PL in human lung fibroblasts and knockdown of SphK1 or treatment with SphK inhibitor attenuated S1P generation and TGF-β mediated signal transduction. Over-expression of S1PL attenuated bleomycin-induced TGF-β secretion and S1P mediated differentiation of human lung fibroblasts through regulation of autophagy. Administration of SphK1 inhibitor 8 days post-bleomycin challenge reduced bleomycin-induced mortality and pulmonary fibrosis. Our results suggest that SphK1 and S1PL play critical roles in the pathology of lung fibrosis and may be novel therapeutic targets.
Keywords: Autophagy; Pulmonary fibrosis; S1P lyase; Sphingosine kinase 1; Sphingosine-1-phosphate; TGF-β.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4291314/bin/nihms634254f1.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4291314/bin/nihms634254f2.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4291314/bin/nihms634254f3.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4291314/bin/nihms634254f4.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4291314/bin/nihms634254f5.gif)
![Fig. 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4291314/bin/nihms634254f6.gif)
![Fig. 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4291314/bin/nihms634254f7.gif)
![Fig. 8](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4291314/bin/nihms634254f8.gif)
![Fig. 9](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4291314/bin/nihms634254f9.gif)
Similar articles
-
Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy.Thorax. 2015 Dec;70(12):1138-48. doi: 10.1136/thoraxjnl-2014-206684. Epub 2015 Aug 18. Thorax. 2015. PMID: 26286721
-
Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.FASEB J. 2013 Apr;27(4):1749-60. doi: 10.1096/fj.12-219634. Epub 2013 Jan 11. FASEB J. 2013. PMID: 23315259 Free PMC article.
-
Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts.Int J Mol Sci. 2020 Mar 17;21(6):2064. doi: 10.3390/ijms21062064. Int J Mol Sci. 2020. PMID: 32192225 Free PMC article.
-
Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: Role of S1P lyase.Adv Biol Regul. 2017 Jan;63:156-166. doi: 10.1016/j.jbior.2016.09.007. Epub 2016 Sep 29. Adv Biol Regul. 2017. PMID: 27720306 Free PMC article. Review.
-
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.Pharmacol Ther. 2020 Mar;207:107464. doi: 10.1016/j.pharmthera.2019.107464. Epub 2019 Dec 18. Pharmacol Ther. 2020. PMID: 31863815 Review.
Cited by
-
Serum S1P level in interstitial lung disease (ILD) is a potential biomarker reflecting the severity of pulmonary function.BMC Pulm Med. 2024 Jun 4;24(1):266. doi: 10.1186/s12890-024-03081-y. BMC Pulm Med. 2024. PMID: 38835000 Free PMC article.
-
The Sphingolipid-Modulating Drug Opaganib Protects against Radiation-Induced Lung Inflammation and Fibrosis: Potential Uses as a Medical Countermeasure and in Cancer Radiotherapy.Int J Mol Sci. 2024 Feb 15;25(4):2322. doi: 10.3390/ijms25042322. Int J Mol Sci. 2024. PMID: 38396999 Free PMC article.
-
Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases.Biomedicines. 2024 Jan 8;12(1):124. doi: 10.3390/biomedicines12010124. Biomedicines. 2024. PMID: 38255229 Free PMC article. Review.
-
Ectopic and visceral fat deposition in aging, obesity, and idiopathic pulmonary fibrosis: an interconnected role.Lipids Health Dis. 2023 Nov 24;22(1):201. doi: 10.1186/s12944-023-01964-3. Lipids Health Dis. 2023. PMID: 38001499 Free PMC article. Review.
-
The role of sphingosine-1-phosphate in autophagy and related disorders.Cell Death Discov. 2023 Oct 18;9(1):380. doi: 10.1038/s41420-023-01681-x. Cell Death Discov. 2023. PMID: 37852968 Free PMC article. Review.
References
-
- Araya J, Kojima J, Takasaka N, Ito S, Fujii S, Hara H, et al. Insufficient autophagy in idiopathic pulmonary fibrosis. American journal of physiology Lung cellular and molecular physiology. 2013;304:L56–L69. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical